These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6813499)

  • 1. 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.
    Schneider MR; von Angerer E; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Sep; 25(9):1070-7. PubMed ID: 6813499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.
    Schneider MR; Ball H; Schiller CD
    J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
    Schneider MR; Ball H; Schönenberger H
    J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic estrogens: anilin mustard linked 1,1,2-triphenylbut-1-enes with mammary tumor inhibiting activity.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1989 Jan; 322(1):59-62. PubMed ID: 2730288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.
    Schneider MR
    J Cancer Res Clin Oncol; 1986; 112(2):119-24. PubMed ID: 3771620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary tumor inhibiting effect of 3,3'-diacetoxy-alpha, beta-dialkylstilbenes and of related stilbene oxides.
    Schneider MR; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Feb; 25(2):141-5. PubMed ID: 7057418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-[4-(N,N-bis-beta-chloroethylcarbamoyloxy)-phenyl]-1,2-bis- (hydroxyphenyl)-but-1-enes: drugs specifically targeted against estrogen receptor positive mammary tumors.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1990 Apr; 323(4):215-9. PubMed ID: 2360864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
    Hartmann RW; Heindl A; Schneider MR; Schönenberger H
    J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.
    Jordan VC; Koch R; Mittal S; Schneider MR
    Br J Pharmacol; 1986 Jan; 87(1):217-23. PubMed ID: 3955300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.
    von Angerer E; Prekajac J
    J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors.
    Schneider MR; Schuderer ML
    J Cancer Res Clin Oncol; 1988; 114(6):583-7. PubMed ID: 3204105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of N,N'-diethyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines on the 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of the rat.
    von Angerer E
    J Med Chem; 1982 Nov; 25(11):1374-7. PubMed ID: 6815325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Verdeal K; Brown RR; Richardson T; Ryan DS
    J Natl Cancer Inst; 1980 Feb; 64(2):285-90. PubMed ID: 6766510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity.
    von Angerer E; Egginger G; Kranzfelder G; Bernhauer H; Schönenberger H
    J Med Chem; 1982 Jul; 25(7):832-7. PubMed ID: 6809943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Garcia M; Rochefort H
    Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
    [No Abstract]   [Full Text] [Related]  

  • 19. A rat cell line derived from DMBA-induced mammary carcinoma.
    Chow LW; Cheung MN; Loo WT; Guan XY
    Life Sci; 2003 May; 73(1):27-40. PubMed ID: 12726884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
    von Angerer E; Birnböck H; Knebel N
    Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.